Articles – Page 14 – Murthy Immigration Services

Possible Termination of Inactive Immigrant Petitions

https://www.murthyindia.com/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 Murthy Immigration Services Murthy Immigration Services https://www.murthyindia.com/wp-content/themes/osmosis/images/empty/thumbnail.jpg April 5, 2022 April 9, 2022

April 5, 2022

Certain immigrant petitions may be terminated if they are inactive for a certain duration. In this article, we explain the circumstances under which this can occur and the precaution an applicant needs to take to prevent this. Circumstances for immigration petition termination per Section 203(g) As per Section 203(g) of the U.S. Immigration and Nationality…

Submission of Interview Waiver Application Made Simpler

April 4, 2022

Effective today, Monday, April 4, 2022, applicants can submit their application for visa at any Visa Application Centers (VAC) where a U.S. consular post is located. For example, if the dropbox appointment is scheduled in New Delhi, the applicant may submit the visa application on the scheduled date and time at any one of the…

Full Vaccination against COVID-19, a prerequisite for Immigrant Visa Appointment

February 7, 2022

The Centers for Disease Control & Prevention has confirmed that if any U.S. visa applicant refuses one or more doses of an approved COVID-19 vaccine that is medically appropriate for and available to the applicant, then this will be documented as a refusal to be vaccinated. This would result in the visa applicant being considered…

Non-immigrant Options when an Immigrant Petition is Pending or Approved

February 7, 2022

In this article, we discuss non-immigrant visa options for Beneficiaries of U.S. immigrant petitions, including the B1/B2 option.Immigrant visa for the United States could take anything from around 12 months to several years depending on the immigrant visa category. If the beneficiary of an immigrant petition, be it employment-based(Form I-140) or family-based (Form I-130) is…

Frequently Asked Question on Drop Box Eligibility Under New Criteria

January 9, 2022

We had recently reported that eligibility criteria for drop box was expanded. Following this, based on inquiries received, we have complied a list of frequently asked question for the benefit of our readers. (1) I have a B1 or F1 visa. I now need to apply for a H or L renewal. Will I qualify?…

Consular Exchange Rate Adjusted

January 3, 2022

On December 17, 2021, the U.S. Embassy in India announced that the Consular Exchange Rate will change from 76 Indian rupees to 1 U.S. dollar to 78 rupees to 1 U.S. dollar. The current rate will be valid through January 3, 2022. As per the U.S Embassy, this change corresponds to recent shifts in the…

Increase in Dropbox Appointments

January 3, 2022

On December 24, 2021, we had reported the U.S. Department of State’s (DOS) decision to expand the scope for visa interview waivers for certain individual petition based nonimmigrant visas. Based on this DOS’s announcement, the U.S. Embassy in India has announced that it will soon release more than 20,000 additional drop box appointments for Spring 2022 in…

Scope Visa Interview Waiver Expanded

December 24, 2021

Last Updated on: February 9, 2022 On December 23, 2021, the U.S. Secretary of State in consultation with the Department of Homeland Security made an announcement that expands the scope for visa interview waiver for certain individual petition based non-immigrant visas. The key takeaways from this announcement are listed below. Temporary Relaxation of Eligibility within…

Updates on Visa Processing at U.S. Consular Posts in India

November 18, 2021

On October 25, 2021, the U.S. President Joe Biden released the much-anticipated proclamation titled “A Proclamation on Advancing the Safe Resumption of Global Travel During the COVID-19 Pandemic”, which came into effect on November 8, 2021, and ended the travel restrictions imposed under P.P. 9984, 9992, 10143, and 10199, suspending entry into the United States…

COVAXIN approved by WHO under Emergency Use List (EUL)

November 3, 2021

The World Health Organization (WHO) on Wednesday, November 3, 2021 issued an Emergency Use List (EUL) to India’s indigenously developed vaccine – COVAXIN (developed by Bharat Biotech). With this approval, COVAXIN is the eighth COVID-19 vaccine validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2. This press release can be found here. Millions…